Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

E Buy Home Inc (ID) EBYH

Strainsforpains, Inc. operates as a medical marijuana data recommendation system. The company develops Strainsforpains app, a user-based application that scientifically determines which cannabis brand or strain is right for patients based upon personal data and strain genetics. It serves medical specialists, dispensaries, and consumers. Strainsforpains, Inc. has a strategic partnership with GenBio, Inc. to license anti-inflammatory compounds in Strainsforpains CBD branded products. The company was incorporated in 1990 and is based in New York, New York.


OTCID:EBYH - Post by User

User Avatar Image
(5)
•••
  • CashSeekerX
Post by CashSeekeron May 14, 2024 9:16am
60 Views
Post# 36038419

EBYH substantial increase in revenues for 2023

EBYH substantial increase in revenues for 2023
$EBYH - Strainsforpains announces substantial increase in revenues for 2023 - Strainsforpains, Inc. is pleased to announce that it has released its annual report, showing increased sales of 1000% from $7400 in 2022 to $84,000 in 2023. The company has announced that its first quarter 2024 has seen a $130,000 order for its CBD products as well.
 
<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities